Evidence map›Paper›PMID 32075876›Full record

ArticleRMD open2020

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.

Elena Elefante, Chiara Tani, Chiara Stagnaro, Francesco Ferro, Alice Parma, Linda Carli, Viola Signorini, Dina Zucchi, Umberto Peta, Adele Santoni and 2 more

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Psychological Implications to the Therapy of Systemic Lupus Erythematosus.International journal of environmental research and public health · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Elena ElefanteDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.ORCID 0000-0003-0657-485X
Chiara TaniDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.ORCID 0000-0002-0870-8738
Chiara StagnaroDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Francesco FerroDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Alice ParmaDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Linda CarliDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Viola SignoriniDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Dina ZucchiDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Umberto PetaDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Adele SantoniDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Leonardo RaffaelliDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy.
Marta MoscaDepartment of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy marta.mosca@med.unipi.it.
University of Pisa · ITUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFatigue is a very common and debilitating symptom in patients with systemic lupus erythematosus (SLE), even among those with a mild or inactive disease. The objective of this study is to define fatigue determinants and describe the impact of fatigue on health-related quality of life (HRQoL) and illness perception in a monocentric cohort of patients with SLE.

methodsThis is a cross-sectional study. Adult patients with SLE were included. For each patient, demographics, medications, comorbidities, organ damage (Systemic Lupus International Collaborating Clinics Damage Index), active disease manifestations and Systemic Lupus Disease Activity Index scores were collected. It was evaluated if each patient met the definitions of remission and low disease activity. At enrolment, each patient completed the Short Form-36 (SF-36), Functional Assessment Chronic Illness Therapy-Fatigue (FACIT-F), Lupus Impact Tracker (LIT), Systemic Lupus Activity Questionnaire (SLAQ) and Brief Index of Lupus Damage (BILD). The FACIT-F questionnaire was also administered to a group of healthy controls.

results223 patients were included (mean age 44.9±13.2 years, median disease duration 13 years). 18.2% had an active disease, 43.5% met the definition of remission on treatment, and 11.8% had a concomitant fibromyalgia. The median FACIT-F score of our cohort was significantly lower compared with that of healthy controls (40 vs 47; p<0.001). FACIT-F scores were irrespective of age, disease duration, disease activity and damage. FACIT-F score was significantly lower in patients with fibromyalgia (p<0.01). FACIT-F scores demonstrated a significant correlation with all other patient-reported outcomes: SF-36 (r=0.53-0.77), LIT (r=-0.78), SLAQ (r=-0.72) and BILD (r=-0.28).

conclusionsFatigue in patients with SLE has a strong negative impact on HRQoL and patient perception of the disease burden. Fatigue seems irrespective of disease activity but significantly influenced by the presence of fibromyalgia.

Indexed as

AdultCase-Control StudiesCohort StudiesCost of IllnessCross-Sectional StudiesFatigueFemaleFibromyalgiaHumansLupus Erythematosus, SystemicMaleMiddle AgedPatient Reported Outcome MeasuresPerceptionQuality of LifeSeverity of Illness Indexautoimmune diseasespatient perspectivesystemic lupus erythematosus

Identifiers

PMID32075876
PMCPMC7046978
OpenAlexW3007600662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.